🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out our full paper in Frontiers - Oncology as well to explore more about the power of integrated WES and RNAseq in Cancer of Unknown Primary! frontiersin.org/journals/oncol…

Congrats to Drs. Juan Miguel Mosquera from Weill Cornell Medicine Pathology & WCM Englander Institute for Precision Medicine, w/Kentaro Ohara and Majd Al Assaad, MD, on "Detection of rare and novel gene fusions in patients with diffuse #glioma: An instit. retrospective study," in J. of Neuropath & Exp. Neuro! academic.oup.com/jnen/advance-a…

🚀Big News! Excited to share our work “The Interplay of Mutagenesis and ecDNA Shapes Urothelial Cancer Evolution” published in nature! nature.com/articles/s4158…

Congratulations to Dr. Carla Stephan, and Weill Cornell Medicine Pathology colleagues, Drs. Majd Al Assaad, MD, Andrea Sboner, PhD @[email protected], and Juan Miguel Mosquera, on their new paper, "Whole genome sequencing elucidates etiological differences in MCPyV-negative #Merkel cell carcinoma." #WGS authors.elsevier.com/a/1jyuA_7qefOn…

And congrats to Weill Cornell Medicine Pathology & WCM Englander Institute for Precision Medicine Drs. Majd Al Assaad (Majd Al Assaad, MD), David C. Wilkes, Andrea Sboner (Andrea Sboner, PhD @[email protected]), Juan Miguel Mosquera; EIPM's Alissa Semaan (Alissa Semaan) and Dir. Olivier Elemento, PhD (Olivier Elemento) for their work on the paper, with Isabl Inc.!

Congrats to our Weill Cornell Medicine Pathology colleagues, Drs. Taylor Kalomeris and Majd Al Assaad, MD, with Dr. Juan Miguel Mosquera, on their new paper "Whole genome profiling of primary and metastatic adrenocortical carcinoma unravels significant molecular events." sciencedirect.com/science/articl…

The diagnosis of neuroendocrine prostate cancer is often challenging. Here is our perspective Clinical Cancer Research on the pathologic work-up of NEPC. With #MHaffner Brian Robinson ROHIT MEHRA Tamara Lotan, MD Mark A. Rubin and many other great colleagues PCF Science pubmed.ncbi.nlm.nih.gov/39589343/

Just published: "Enhancing the Detection of Clinically Relevant #Biomarkers in Advanced Uterine and Tubo-Ovarian Carcinomas Through Genome-Wide Analysis," by Weill Cornell Medicine Pathology's Majd Al Assaad, MD, Drs. Baris Boyraz, Juan Miguel Mosquera, Isabl Inc. WCM Englander Institute for Precision Medicine authors.elsevier.com/sd/article/S03…

New paper: "Emerging molecular phenotypes & potential therapeutic targets in esophageal and gastric #adenocarcinoma unearthed by whole genome and transcriptome analyses," by Weill Cornell Medicine Pathology Drs. Annika Windon, Majd Al Assaad, MD & Juan Miguel Mosquera et al #WGS sciencedirect.com/science/articl…

Congratulations to Drs. Jesús Delgado-de la Mora, Majd Al Assaad, MD Andrea Sboner, PhD @[email protected] Erika Hissong and Juan Miguel Mosquera from Weill Cornell Medicine Pathology and WCM Englander Institute for Precision Medicine; with EIPM's Jyothi Manohar and Michael Sigouros; and our Director Dr. Elemento (Olivier Elemento) & Dr. Allyson Ocean for their contributions!

‼️🚨The best current evidence on the role of HPV in Penile Cancer: A Meta-Analysis by our group Moffitt Cancer Center Philippe spiess Anna Giuliano Curtis Pettaway, MD Majd Al Assaad, MD ACS National HPV Vaccination Roundtable Houssein Safa, MD NCCC HPV Action Network Massachusetts HPV Coalition HPV-cancer.org doi.org/10.6004/jnccn.…

New research by WCM Englander Institute for Precision Medicine and Weill Cornell Medicine Pathology in AACR's Cancer Research shows feasibility of #CRISPR-based genetic screens in patient-derived #organoids, including #PDTOs from underrepresented with #cancer, and identify targets for cancer therapy. aacrjournals.org/cancerres/arti…

New research by Weill Cornell Medicine Pathology and WCM Englander Institute for Precision Medicine in International Institute of Anticancer Research, "Unusual Presentation of Advanced #UrothelialCancer in a Young Patient," highlights the complexity of treatment and importance of #precisionmedicine and innovative treatment options. ar.iiarjournals.org/content/45/2/6…

I’m beyond grateful to share that I’ve matched into Weill Cornell Medicine Pathology. Thank you to everyone who’s been part of this journey—couldn’t have done it without your support. Looking forward to the next chapter at this amazing program! #Match2025 #pathmatch2025

Congratulations to Dr. Majd Al Assaad (Majd Al Assaad, MD) from the Weill Cornell Medicine Pathology & WCM Englander Institute for Precision Medicine on your exciting #pathmatch2025! #Match2025

Congratulations to all of our 2025-2026 incoming Weill Cornell Medicine Pathology Residents! #Match2025 #pathmatch2025

Grateful to share a piece of our work at the intersection of pathology and precision medicine. Honored to be part of this team. Weill Cornell Medicine Pathology WCM Englander Institute for Precision Medicine #precisionmedicine #USCAP2025

1/ Excited to share our new paper in npj Digital Medicine. We worked with Fei Wang to develop a cutting-edge AI model 🖥️ that predicts response to neoadjuvant chemotherapy 💉 in patients with muscle-invasive #bladdercancer in the S1314 randomized clinical trial

Congratulations to Weill Cornell Medicine Pathology's Dr. Juan Miguel Mosquera, NY Genome Center's Dr. Nicolas Robine (Nicolas Robine), and WCM's Dr. Jones Nauseef on their new paper, "A complex phylogeny of lineage plasticity in metastatic castration resistant #prostatecancer." rdcu.be/efyzi

Congrats to Weill Cornell Medicine Pathology Drs. Majd Al Assaad, MD, Solomon & Mosquera on their preprint "Comparison of #WGS with Clinical Targeted Panel Sequencing of Metastatic #ProstateCancer: Insights from Real-World Data", with WCM Englander Institute for Precision Medicine Inocras & Henry Ford Health researchsquare.com/article/rs-699…